Market Place
Sourcing Support
Cosette Pharma`s Generics Sucralfate Receives Approval in US
13 Nov 2024 //
FDA
Palatin Updates On Clinical Programs And Strategic Priorities
09 Sep 2024 //
PR NEWSWIRE
Avista And Hamilton Lane Partner In Cosette Pharmaceuticals
17 Jul 2024 //
PR NEWSWIRE
Cosette Pharma Acquires Ambien And Ambien CR From Sanofi US
10 Jul 2024 //
BUSINESSWIRE
Cosette Announces the Approval and Launch of First Generic Version of RECTIV
22 Feb 2024 //
BUSINESSWIRE
Palatin Completes Sale of Vyleesi® to Cosette Pharma for up to $171 Million
20 Dec 2023 //
PR NEWSWIRE
Cosette Launches Metronidazole Vaginal Gel 0.75%, AB-rated to MetroGel-Vaginal
27 Jul 2023 //
BUSINESSWIRE
Cosette Pharmaceuticals Launches Dapsone 5% Gel, AB-Rated to Aczone® 5%
13 Jul 2023 //
BUSINESSWIRE
Cosette Pharmaceuticals Launches Betaine Anhydrous Powder
02 Mar 2023 //
BUSINESSWIRE
Cosette Pharma Announces the Approval and Launch of Metronidazole Gel USP, 1%
09 Feb 2023 //
BUSINESSWIRE
Cosette`s Generic Metronidazole Receives Approval in the U.S.
23 Jan 2023 //
FDA
Cosette Announces the launch of Griseofulvin Oral Suspension, 125 mg/5 mL.
06 Dec 2022 //
BUSINESSWIRE
Cosette Pharmaceuticals Appoints Kevin Hickey, VP, Brand Sales and Marketing
17 Nov 2022 //
BUSINESSWIRE
Cosette Pharmaceuticals Appoints Kevin Hickey, Vice President
17 Nov 2022 //
BUSINESSWIRE
Cosette Announces the Approval and Launch of First Generic Versions of TAZORAC
20 Sep 2022 //
BUSINESSWIRE
Cosette`s Generic Tazarotene Receives Approval in the U.S.
13 Sep 2022 //
FDA
Cosette Pharmaceuticals Appoints Rick Casten as CFO Amid Transformational Growth
06 Jul 2022 //
BUSINESSWIRE
Cosette Pharmaceuticals Receives U.S. Patent For Welchol Chewable Bar
07 Jun 2022 //
BUSINESSWIRE
Cosette Pharma, Alembic Pharma Announce the Approval and Launch of NBE of Abreva
24 May 2022 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.